Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 1, 2008Journal of Clinical Oncology

Relationship Between Obesity and Pathologic Response to Neoadjuvant Chemotherapy Among Women With Operable Breast Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

JLJennifer K. LittonThe University of Texas MD Anderson Cancer CenterAGAna M. González-AnguloIntermountain HealthcareCWCarla L. WarnekeThe University of Texas MD Anderson Cancer Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Litton et al. (2008) studied this question.

synapsesocial.com/papers/69de760f6e50a6aba3e93ac9https://doi.org/10.1200/jco.2007.14.4527
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Obesity as an Adverse Prognostic Factor for Patients Receiving Adjuvant Chemotherapy for Breast Cancer1994 · 173 citations
  2. 2Doxorubicin clearance in the obese.1988 · 213 citations
  3. 3Outcome After Pathologic Complete Eradication of Cytologically Proven Breast Cancer Axillary Node Metastases Following Primary Chemotherapy2005 · 429 citations
  4. 4Sequential Preoperative or Postoperative Docetaxel Added to Preoperative Doxorubicin Plus Cyclophosphamide for Operable Breast Cancer: National Surgical Adjuvant Breast and Bowel Project Protocol B-272006 · 950 citations
  5. 5Obesity and Outcomes in Premenopausal and Postmenopausal Breast Cancer2005 · 328 citations